Literature DB >> 12152141

Breast engorgement and galactorrhea during magnesium sulfate treatment of preterm labor.

Samuel Lurie1, Sigi Rotmensch, Noa Feldman, Marek Glezerman.   

Abstract

Breast engorgement and galactorrhea occasionally occur during tocolysis with ritodrine. We are not aware of breast engorgement and galactorrhea associated with other tocolytics. We report the first case of breast engorgement and galactorrhea during tocolysis with intravenous magnesium sulfate in a generally healthy 24-year-old woman admitted for tocolysis at 30 weeks' gestation. Breast engorgement and galactorrhea gradually subsided after magnesium sulfate was discontinued. The rapid disappearance of both the galactorrhea and the breast engorgement after discontinuation of magnesium sulfate treatment suggests a cause-effect relationship, the mechanism of which remains unclear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12152141     DOI: 10.1055/s-2002-33086

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

1.  ABM Clinical Protocol #20: Engorgement, Revised 2016.

Authors:  Pamela Berens; Wendy Brodribb
Journal:  Breastfeed Med       Date:  2016-04-12       Impact factor: 1.817

Review 2.  Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Authors:  Emily S Bain; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-21       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.